The Advisory Committee is an esteemed group of industry thought leaders assembled by BIO to shape this event’s conference program by collaboratively identifying topics and speakers that will facilitate engaging and informative discussions.
Henry Chen, JD, Managing Partner, Delos Capital
Kyle Hathaway, PhD, Director of Policy and Government Relations, Asia Pacific, MSD
Apo Huang, PhD, Secretary General, Taiwan Bio Industry Organization
Taro Inaba, Managing Partner, Remiges Ventures
Yuichi Iwaki, MD, PhD, President, Chief Executive Officer, and Fouder, MediciNova
Amy Jackson, Japan Representative, PhRMA
Shinichiro Komoto, Partner, Eight Roads
Ryo Kubota, MD, PhD, Representative Executive Officer, Chairman, President and Chief Executive Officer, Kubota Pharmaceutical Holdings Co., Ltd.
Arlene Morris, Chief Executive Officer, Willow Advisors LLC
Kyle Murphy, Managing Director and Founder, KMG Japan
Masako Nakamura, Head of Asia, Alnylam Pharmaceuticals; President and Representative Director, Alnylam Japan K.K
Paul Neureiter, Executive Director for International Government Affairs, Amgen
Toru Seo, PhD, APAC Lead, Scout & Evaluation, Worldwide Business Development, Pfizer, Inc.
Gurkeerat Singh, PhD, Vice President, Emerging Technology and Innovation, Eli Lilly and Company
Charles Stacey, MD, Chief Executive Officer, Cerecin
Ted Tanaka, Partnering Consultant, Tanaka International LLC
Gil Van Bokkelen, PhD, Chairman and Chief Executive Officer, Athersys